MYC and glioblastoma: Next, we used in vitro culture of patient-derived GBM cells (1079 and 413) and confirmed that Myc was significantly upregulated at both the mRNA and protein levels in response to addition of the rEndocan to all tested cells (Figs. 5f, g, S6d).